EcoDrugPlus

Protein Phosphatase 3 Catalytic Subunit Alpha

Ensembl ID : ENSSVLG00005008404
Gene Symbol: PPP3CA
1 Cross references
230 Possible Orthologues:

Protein Tyrosine Kinase 2 Beta

Ensembl ID : ENSSVLG00005002627
Gene Symbol: PTK2B
1 Cross references
269 Possible Orthologues:

Protein Tyrosine Kinase 6

Ensembl ID : ENSSVLG00005010733
Gene Symbol: PTK6
1 Cross references
170 Possible Orthologues:

Purine Nucleoside Phosphorylase

Ensembl ID : ENSSVLG00005001773
Gene Symbol: PNP
1 Cross references
429 Possible Orthologues:

Purinergic Receptor P2x 3

Ensembl ID : ENSSVLG00005017251
Gene Symbol: P2RX3
1 Cross references
270 Possible Orthologues:

Purinergic Receptor P2x 7

Ensembl ID : ENSSVLG00005008511
Gene Symbol: P2RX7
1 Cross references
187 Possible Orthologues:

Purinergic Receptor P2y1

Ensembl ID : ENSSVLG00005007265
Gene Symbol: P2RY1
1 Cross references
190 Possible Orthologues:

Purinergic Receptor P2y12

Ensembl ID : ENSSVLG00005007889
Gene Symbol: P2RY12
1 Cross references
180 Possible Orthologues:

Purinergic Receptor P2y2

Ensembl ID : ENSSVLG00005017053
Gene Symbol: P2RY2
1 Cross references
197 Possible Orthologues:

Pyrimidinergic Receptor P2y4

Ensembl ID : ENSSVLG00005018235
Gene Symbol: P2RY4
1 Cross references
165 Possible Orthologues:

Pyrimidinergic Receptor P2y6

Ensembl ID : ENSSVLG00005017079
Gene Symbol: P2RY6
1 Cross references
182 Possible Orthologues:

Receptor Activity Modifying Protein 1

Ensembl ID : ENSSVLG00005023605
Gene Symbol: RAMP1
1 Cross references
253 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).